Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÀÀ±Þ½ÇÀ» ¹æ¹®ÇÑ ¼Ò¾Æ º¹ÅëȯÀÚ¿¡¼­ Çѱ¹Çü ÀÀ±ÞȯÀÚ ºÐ·ùµµ±¸¿¡ µû¸¥ ÁßÁõµµ¿Í ÀÔ¿øÀÇ ¿¬°ü Association between the Korean Triage and Acuity Scale level and hospitalization of children with abdominal pain in the emergency department

´ëÇѼҾÆÀÀ±ÞÀÇÇÐȸÁö 2017³â 4±Ç 2È£ p.97 ~ 101
±è¼¼ÈÆ, ¿ì¼±Èñ, ÃÖ°æÈ£, ¿À¿µ¹Î, ÃÖ¼¼¹Î,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¼¼ÈÆ ( Kim Se-Hoon ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇÁ¤ºÎ¼º¸ðº´¿ø ÀÀ±ÞÀÇÇб³½Ç

¿ì¼±Èñ ( Woo Seon-Hee ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ÀÎõ¼º¸ðº´¿ø ÀÀ±ÞÀÇÇб³½Ç
ÃÖ°æÈ£ ( Choi Kyung-Ho ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇÁ¤ºÎ¼º¸ðº´¿ø ÀÀ±ÞÀÇÇб³½Ç
¿À¿µ¹Î ( Oh Young-Min ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇÁ¤ºÎ¼º¸ðº´¿ø ÀÀ±ÞÀÇÇб³½Ç
ÃÖ¼¼¹Î ( Choi Se-Min ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇÁ¤ºÎ¼º¸ðº´¿ø ÀÀ±ÞÀÇÇб³½Ç

Abstract


Purpose: The Korean Triage and Acuity Scale (KTAS) is a triage tool for patients in the emergency department (ED). We aimed to investigate the association between the KTAS level and hospitalization of children with abdominal pain, a common chief complaint in the ED.

Methods: This study retrospectively reviewed medical records of children aged 3 to 14 years who visited the ED with abdominal pain as a chief complaint. KTAS level (1-3 vs. 4-5), age, gender, presence of associated symptoms (vomiting, diarrhea, hematochezia, and fever), and disposition (rapid discharge, discharge after intravenous hydration, and hospitalization) were collected and compared between the children with KTAS 1-3 and 4-5.

Results: Of 1,050 children enrolled, 618 (58.9%) were classified as KTAS 1-3, and 36 (3.4%) were hospitalized. Vomiting was the most common associated symptom in both groups (63.6%), and 41.5% underwent discharge after intravenous hydration. The children with KTAS 1-3 were more frequently hospitalized (5.0% vs. 1.2%, P < 0.001).

Conclusion: The KTAS may be reliable to predict the hospitalization of children with abdominal pain in the ED with additional consideration of the associated symptoms.

Å°¿öµå

Abdominal Pain; Critical Illness; Emergency Medicine; Pediatrics; Triage

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed